首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1269610

2022-2029年全球避孕藥物市場規模研究和預測，按產品、配銷通路和區域分析

Global Contraceptive Drugs Market Size study & Forecast, by Product, by Distribution Channel and Regional Analysis, 2022-2029

出版日期: 2023年05月02日 | 出版商:

Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2021年，全球避孕藥市場價值約為165.9億美元，預計在2022-2029年的預測期內將以超過7.4%的健康成長率成長。女性為控制生育而使用避孕藥。避孕藥市場日益擴大，因為意外懷孕的發生率越來越高，性傳播疾病（STD）的流行率越來越高。然而，不孕症發病率的上升和與使用避孕藥物和設備有關的不良反應可能會阻礙市場成長。

在整個預測期內，市場成長預計將受到性傳播疾病（STD）發病率上升和未滿足避孕藥物和設備需求的婦女人數增加的推動。根據世界衛生組織的資料，2019年全球有近11億育齡婦女（15至49歲）需要計劃生育。其中超過8.42億人使用避孕技術進行計劃生育，其中有2.7億人的避孕需求沒有得到滿足。此外，聯合國經濟和社會事務部人口司報告說，在2019年，世界上有19億育齡婦女（15-49歲）。約有8000萬人使用常規方法，而約有8.42億婦女使用現代避孕方法，包括口服藥物和注射劑。此外，人們對避孕藥物的認識不斷提高，促使產品的需求，為市場創造了有利的成長。除此以外，已開發國家廣泛的報銷政策預計將在預測期內推動市場的採用率。

全球避孕藥物市場研究的主要地區包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於品牌產品的主導地位和該地區日益成長的疾病流行率，北美在收入方面主導了市場。而亞太地區在預測期內預計將以最高的年複合成長率成長，原因是老年疾病和目標人群的增加，生物仿製藥開發合作的數量增加，主要參與者的地理擴張，以及政府和非營利組織對市場空間的積極參與。

該研究的目的是確定近年來不同領域和國家的市場規模，並預測未來幾年的價值。本報告旨在將研究涉及的國家內的產業的品質和數量方面都涵蓋其中。

本報告還提供了關於關鍵方面的詳細資訊，如驅動因素和挑戰，這將確定市場的未來成長。此外，還涵蓋了微觀市場的潛在機會，供利益相關者投資，並詳細分析了競爭格局和主要參與者的產品。

避孕藥市場影響分析(2019-2029)
- 市場驅動力
  - 政府和非政府組織推廣避孕方法的計劃
  - 意外懷孕的發生率不斷上升
- 市場挑戰
  - 不孕不育症的發病率上升
  - 與使用避孕藥物和裝置有關的不良反應
- 市場機會
  - 性傳播疾病（STD）的發病率不斷上升

第四章：全球避孕藥物市場產業分析

波特的5力模型
- 供應商的議價能力
- 買方的議價能力
- 新進入者的威脅
- 替代品的威脅
- 競爭性的競爭
波特五力模型的未來方法（2019-2029年）
PEST分析
- 政治因素
- 經濟
- 社會
- 技術
最佳投資機會
最佳策略
產業專家展望
分析師建議和結論

第五章：風險評估：COVID-19的影響

評估COVID-19對產業的整體影響
COVID-19前和COVID-19後的市場情況

第六章：全球避孕藥物市場，按產品分類

市場簡介
全球避孕藥物市場，按產品，性能-潛力分析
2019-2029年全球避孕藥物市場按產品的估計和預測
避孕藥市場，細項分析
- 口服
- 注射式
- 藥片

第7章：全球避孕藥物市場，按配銷通路分類

市場簡介
按配銷通路分類的全球避孕藥物市場，表現- 潛力分析
2019-2029年全球避孕藥物市場按配銷通路的估計和預測
避孕藥市場，細項分析
- 醫院藥房
- 零售藥店
- 診所
- 線上管道
- 公共管道和非政府組織
- 其他管道

第八章：全球避孕藥具市場，區域分析

避孕藥市場，區域市場簡介
北美洲
- 美國
  - 產品分類估計和預測，2019-2029年
  - 2019-2029年配銷通路細分估計和預測
- 加拿大
歐洲避孕藥物市場簡介
- 英國
- 德國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區避孕藥物市場簡介
- 中國
- 印度
- 日本
- 澳大利亞
- 韓國
- 亞太其他地區
拉丁美洲避孕藥物市場簡介
- 巴西
- 墨西哥
- 拉丁美洲其他地區
世界其他地區

第九章：競爭情報

頂級市場戰略
公司簡介
- Piramal Enterprises Ltd.
  - 關鍵資訊
  - 概況
  - 財務（取決於資料的可用性）
  - 產品摘要
  - 近期發展情況
- Organon group of companies
- Johnson & Johnson Services, Inc.
- AbbVie Inc.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Amneal Pharmaceuticals, Inc.
- Bayer AG
- Agile Therapeutics

第十章：研究過程

研究過程
- 資料探勘
- 資料分析
- 市場評估
- 驗證
- 出版
研究屬性
研究假設

簡介目錄圖表

Global Contraceptive Drugs Market is valued approximately USD 16.59 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2022-2029. Contraceptive Drugs are consumed by female for birth control. The Contraceptive Drugs market is expanding because of factors such as increasing prevalence of unwanted pregnancies and increasing prevalence of sexually transmitted diseases (STDs). However, rising prevalence of infertility and adverse effects associated with the use of contraceptive drugs and devices may halt market growth.

Throughout the forecast period, the market growth is anticipated to be driven by the rising incidence of Sexually Transmitted Diseases (STDs) and the rising number of women with unmet need for contraceptive medications & devices. Almost 1.1 billion women worldwide in 2019 who are reproductive age (15 to 49 years) need family planning, according to the World Health Organization. Over 842 million of them use contraceptive techniques for family planning, and 270 million of them have unmet contraception needs. Furthermore, The Department of Economic and Social Affairs, Population Division of the United Nations reports that in 2019 that there are 1.9 billion women in the world who are reproductive age (15-49). Around 80 million people utilize conventional methods, while about 842 million women use contemporary contraception, including oral medications and injectables. In addition, growing awareness regarding contraceptive drugs leads to product demand creating a lucrative growth to the market. Along with these, wide availability of reimbursement policies in developed countries is expected to fuel the market adoption rate in the forecasted period.

The key regions considered for the Global Contraceptive Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:

Piramal Enterprises Ltd.
Organon group of companies
Johnson & Johnson Services, Inc.
AbbVie Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Amneal Pharmaceuticals, Inc.
Bayer AG
Agile Therapeutics.

Recent Developments in the Market:

In February 2020, The U.S. FDA has authorized Agile Therapeutics to commercialize Twirla (levonorgestrel and ethinyl estradiol), a transdermal patch for women.
In January 2020, Bayer AG and Dare Bioscience, Inc. have signed a licence agreement to distribute Ovaprene after the U.S. Food and Drug Administration gives the experimental contraception medicine market clearance.

Global Contraceptive Drugs Market Report Scope:

Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

Oral
Injectable
Patches

By Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Clinics
Online Channels
Public Channels & NGOs
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Contraceptive Drugs Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Contraceptive Drugs Market, by Product, 2019-2029 (USD Billion)
- 1.2.3. Contraceptive Drugs Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Contraceptive Drugs Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Contraceptive Drugs Market Dynamics

3.1. Contraceptive Drugs Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Government and NGO initiatives to promote contraceptive methods
  - 3.1.1.2. Increasing prevalence of unwanted pregnancies
- 3.1.2. Market Challenges
  - 3.1.2.1. Rising prevalence of infertility
  - 3.1.2.2. Adverse effects associated with the use of contraceptive drugs and devices
- 3.1.3. Market Opportunities
  - 3.1.3.1. Increasing prevalence of sexually transmitted diseases (STDs)

Chapter 4. Global Contraceptive Drugs Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Contraceptive Drugs Market, by Product

6.1. Market Snapshot
6.2. Global Contraceptive Drugs Market by Product, Performance - Potential Analysis
6.3. Global Contraceptive Drugs Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Contraceptive Drugs Market, Sub Segment Analysis
- 6.4.1. Oral
- 6.4.2. Injectable
- 6.4.3. Patches

Chapter 7. Global Contraceptive Drugs Market, by Distribution Channel

7.1. Market Snapshot
7.2. Global Contraceptive Drugs Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Contraceptive Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
7.4. Contraceptive Drugs Market, Sub Segment Analysis
- 7.4.1. Hospital Pharmacy
- 7.4.2. Retail Pharmacy
- 7.4.3. Clinics
- 7.4.4. Online Channels
- 7.4.5. Public Channels & NGOs
- 7.4.6. Others

Chapter 8. Global Contraceptive Drugs Market, Regional Analysis

8.1. Contraceptive Drugs Market, Regional Market Snapshot
8.2. North America Contraceptive Drugs Market
- 8.2.1. U.S. Contraceptive Drugs Market
  - 8.2.1.1. Product breakdown estimates & forecasts, 2019-2029
  - 8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
- 8.2.2. Canada Contraceptive Drugs Market
8.3. Europe Contraceptive Drugs Market Snapshot
- 8.3.1. U.K. Contraceptive Drugs Market
- 8.3.2. Germany Contraceptive Drugs Market
- 8.3.3. France Contraceptive Drugs Market
- 8.3.4. Spain Contraceptive Drugs Market
- 8.3.5. Italy Contraceptive Drugs Market
- 8.3.6. Rest of Europe Contraceptive Drugs Market
8.4. Asia-Pacific Contraceptive Drugs Market Snapshot
- 8.4.1. China Contraceptive Drugs Market
- 8.4.2. India Contraceptive Drugs Market
- 8.4.3. Japan Contraceptive Drugs Market
- 8.4.4. Australia Contraceptive Drugs Market
- 8.4.5. South Korea Contraceptive Drugs Market
- 8.4.6. Rest of Asia Pacific Contraceptive Drugs Market
8.5. Latin America Contraceptive Drugs Market Snapshot
- 8.5.1. Brazil Contraceptive Drugs Market
- 8.5.2. Mexico Contraceptive Drugs Market
- 8.5.3. Rest of Latin America Contraceptive Drugs Market
8.6. Rest of The World Contraceptive Drugs Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies
9.2. Company Profiles
- 9.2.1. Piramal Enterprises Ltd.
  - 9.2.1.1. Key Information
  - 9.2.1.2. Overview
  - 9.2.1.3. Financial (Subject to Data Availability)
  - 9.2.1.4. Product Summary
  - 9.2.1.5. Recent Developments
- 9.2.2. Organon group of companies
- 9.2.3. Johnson & Johnson Services, Inc.
- 9.2.4. AbbVie Inc.
- 9.2.5. Pfizer Inc.
- 9.2.6. Teva Pharmaceutical Industries Ltd.
- 9.2.7. Viatris Inc.
- 9.2.8. Amneal Pharmaceuticals, Inc.
- 9.2.9. Bayer AG
- 9.2.10. Agile Therapeutics

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

簡介目錄圖表

LIST OF TABLES

TABLE 1. Global Contraceptive Drugs Market, report scope
TABLE 2. Global Contraceptive Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Contraceptive Drugs Market estimates & forecasts by Product 2019-2029 (USD Billion)
TABLE 4. Global Contraceptive Drugs Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 5. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Contraceptive Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Contraceptive Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Contraceptive Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Contraceptive Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Contraceptive Drugs Market
TABLE 70. List of primary sources, used in the study of global Contraceptive Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered